Literature DB >> 4346033

Release of infectious Epstein-Barr virus by transformed marmoset leukocytes.

G Miller, M Lipman.   

Abstract

Marmoset blood leukocytes transformed in vitro by Epstein-Barr virus regularly release extracellular infectious Epstein-Barr virus with high titers of transforming activity. By comparison, human umbilical cord leukocytes and adult human leukocytes transformed by Epstein-Barr virus release either no extracellular infectious virus or small amounts, irregularly.

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4346033      PMCID： PMC433213          DOI： 10.1073/pnas.70.1.190

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


  8 in total

1.  Epstein-Barr virus: transformation, cytopathic changes, and viral antigens in squirrel monkey and marmoset leukocytes.

Authors:  G Miller; T Shope; H Lisco; D Stitt; M Lipman
Journal:  Proc Natl Acad Sci U S A       Date:  1972-02       Impact factor: 11.205

2.  Establishment of cell lines from normal adult human blood leukocytes by exposure to Epstein-Barr virus and neutralization by human sera with Epstein-Barr virus antibody.

Authors:  G Miller; H Lisco; H I Kohn; D Stitt; J F Enders
Journal:  Proc Soc Exp Biol Med       Date:  1971-09

3.  Occurrence of Epstein-Barr virus genomes in human lymphoblastoid cell lines.

Authors:  H zur Hansen; V Diehl; H Wolf; H Schulte-Holthausen; U Schneider
Journal:  Nat New Biol       Date:  1972-06-07

4.  Detection of Epstein-Barr viral genome in nonproductive cells.

Authors:  M Nonoyama; J S Pagano
Journal:  Nat New Biol       Date:  1971-09-22

5.  Epstein-Barr viral antigen in single cell clones of two human leukocytic lines.

Authors:  M H Miller; D Stitt; G Miller
Journal:  J Virol       Date:  1970-11       Impact factor: 5.103

6.  Incidence of EB virus-containing cells in primary and secondary clones of several Burkitt lymphoma cell lines.

Authors:  B A Maurer; S M Wilbert; T Imamura
Journal:  Cancer Res       Date:  1970-12       Impact factor: 12.701

7.  Immunofluorescence in cells derived from Burkitt's lymphoma.

Authors:  G Henle; W Henle
Journal:  J Bacteriol       Date:  1966-03       Impact factor: 3.490

8.  Epstein-Barr virus antigens, marker chromosome, and interferon production in clones derived from cultured Burkitt tumor cells.

Authors:  B A Zajac; G Kohn
Journal:  J Natl Cancer Inst       Date:  1970-08       Impact factor: 13.506
  8 in total
  330 in total

1.  Determining the role of the Epstein-Barr virus Cp EBNA2-dependent enhancer during the establishment of latency by using mutant and wild-type viruses recovered from cottontop marmoset lymphoblastoid cell lines.

Authors:  L Yoo; S H Speck
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  Type 2 cytokines predominate in the human CD4(+) T-lymphocyte response to Epstein-Barr virus nuclear antigen 1.

Authors:  P Steigerwald-Mullen; M G Kurilla; T J Braciale
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

3.  Molecular cytogenetic characterization of the EBV-producing cell line B95-8 (Saguinus oedipus, Platyrrhini) by chromosome sorting and painting.

Authors:  S Müller; M Neusser; P C O'Brien; J Wienberg
Journal:  Chromosome Res       Date:  2001       Impact factor: 5.239

4.  Major histocompatibility complex class II invariant chain expression in non-antigen-presenting cells.

Authors:  H Veenstra; W F Ferris; P J Bouic
Journal:  Immunology       Date:  2001-06       Impact factor: 7.397

5.  Autostimulation of the Epstein-Barr virus BRLF1 promoter is mediated through consensus Sp1 and Sp3 binding sites.

Authors:  T Ragoczy; G Miller
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

6.  A new primary effusion lymphoma-derived cell line yields a highly infectious Kaposi's sarcoma herpesvirus-containing supernatant.

Authors:  J S Cannon; D Ciufo; A L Hawkins; C A Griffin; M J Borowitz; G S Hayward; R F Ambinder
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

7.  Studies on the interaction between alpha-gliadin and HLA and T cell receptor molecules in coeliac disease.

Authors:  R B Gallagher; C Feighery; D G Weir; C P Kelly; C A Whelan
Journal:  Clin Exp Immunol       Date:  1988-12       Impact factor: 4.330

8.  (-)-Epigallocatechin-3-gallate inhibition of Epstein-Barr virus spontaneous lytic infection involves downregulation of latent membrane protein 1.

Authors:  Sufang Liu; Hongde Li; Min Tang; Ya Cao
Journal:  Exp Ther Med       Date:  2017-11-13       Impact factor: 2.447

9.  Maternally inherited aminoglycoside-induced and nonsyndromic deafness is associated with the novel C1494T mutation in the mitochondrial 12S rRNA gene in a large Chinese family.

Authors:  Hui Zhao; Ronghua Li; Qiuju Wang; Qingfeng Yan; Jian-Hong Deng; Dongyi Han; Yidong Bai; Wie-Yen Young; Min-Xin Guan
Journal:  Am J Hum Genet       Date:  2003-12-12       Impact factor: 11.025

10.  An integral membrane protein (LMP2) blocks reactivation of Epstein-Barr virus from latency following surface immunoglobulin crosslinking.

Authors:  C L Miller; J H Lee; E Kieff; R Longnecker
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-18       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.